
    
      The objective of this PMS will be to monitor and gather data on the safety of The Medtronic
      Transcatheter Aortic Valve Implant System (CoreValve System Family) in the approved intended
      use.

      The main focus of this PMS will be to generate additional information and report on all major
      adverse events up to 30 days from the day of implant procedure.
    
  